No results for ‘’
Amkay Products Ltd
NSE: BSE: 544169
₹51.75
(11.97%)
Wed, 09 Sept 2026, 11:52 pm
Market Cap (in Cr)50.89
PE Ratio19.36
Dividend0
Health Technology
Medical Specialties
24.5KAmkay Products Cashflow
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Deprecation and amortization | -2.83M | -5.37M | -6.91M | -5.56M | -8.29M |
| Accumulated depreciation, total | -37.16M | -42.54M | -57.61M | -63.16M | -70.86M |
| Cash from operating activities | 62.93M | -24.67M | -1.05M | -11.51M | -4.94M |
| Funds from operations | 33.53M | 20.66M | 17.07M | 22.56M | 31.01M |
| Net income (cash flow) | 31.27M | 14.67M | 15.49M | 26.30M | 33.38M |
| Depreciation & amortization (cash flow) | 2.83M | 5.37M | 6.91M | 5.56M | 8.29M |
| Depreciation/depletion | 2.83M | 5.37M | 6.91M | 5.56M | 8.29M |
| Amortization | — | — | — | — | — |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | -11.07M | -5.07M | -12.16M | -18.01M | -20.27M |
| Changes in working capital | 29.40M | -45.32M | -18.12M | -34.06M | -35.95M |
| Cash from investing activities | -20.56M | -32.13M | -4.43M | 4.47M | -59.81M |
| Capital expenditures | -12.01M | -21.50M | -234.00K | -11.60M | -27.33M |
| Capital expenditures - fixed assets | -12.01M | -21.50M | -234.00K | -7.30M | -24.75M |
| Capital expenditures - other assets | 0 | 0 | 0 | -4.30M | -2.58M |
| Cash from financing activities | -5.11M | 29.70M | 5.36M | 7.62M | 79.03M |
| Free cash flow | 50.92M | -46.17M | -1.28M | -18.81M | -29.69M |